Related references
Note: Only part of the references are listed.Label-Free Enrichment and Molecular Characterization of Viable Circulating Tumor Cells from Diagnostic Leukapheresis Products
Andre Franken et al.
CLINICAL CHEMISTRY (2019)
Toward a real liquid biopsy in metastatic breast and prostate cancer: Diagnostic LeukApheresis increases CTC yields in a European prospective multicenter study (CTCTrap)
Kiki C. Andree et al.
INTERNATIONAL JOURNAL OF CANCER (2018)
The biology and role of CD44 in cancer progression: therapeutic implications
Chen Chen et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2018)
Diagnostic leukapheresis for CTC analysis in breast cancer patients: CTC frequency, clinical experiences and recommendations for standardized reporting
Tanja N. Fehm et al.
CYTOMETRY PART A (2018)
Tracking evolution of aromatase inhibitor resistance with circulating tumour DNA analysis in metastatic breast cancer
C. Fribbens et al.
ANNALS OF ONCOLOGY (2018)
Isolation and characterization of circulating tumor cells using a novel workflow combining the CellSearch® system and the CellCelector
Martin Horst Dieter Neumann et al.
BIOTECHNOLOGY PROGRESS (2017)
CD24 expression is a marker for predicting clinical outcome and regulates the epithelial-mesenchymal transition in ovarian cancer via both the Akt and ERK pathways
Kiyoko Nakamura et al.
ONCOLOGY REPORTS (2017)
Navigation through inter- and intratumoral heterogeneity of endocrine resistance mechanisms in breast cancer: A potential role for Liquid Biopsies?
Florian Reinhardt et al.
TUMOR BIOLOGY (2017)
CDK4/6 Inhibition in Breast Cancer: Mechanisms of Response and Treatment Failure
Ana C. Garrido-Castro et al.
CURRENT BREAST CANCER REPORTS (2017)
Accession of Tumor Heterogeneity by Multiplex Transcriptome Profiling of Single Circulating Tumor Cells
Tobias M. Gorges et al.
CLINICAL CHEMISTRY (2016)
Circulating tumor cells in breast cancer
Francois-Clement Bidard et al.
MOLECULAR ONCOLOGY (2016)
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
G. N. Hortobagyi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Palbociclib in Hormone-Receptor-Positive Advanced Breast Cancer
Nicholas C. Turner et al.
NEW ENGLAND JOURNAL OF MEDICINE (2015)
Transcriptional Bursting in Gene Expression: Analytical Results for General Stochastic Models
Niraj Kumar et al.
PLOS COMPUTATIONAL BIOLOGY (2015)
Optimization and Evaluation of a Novel Size Based Circulating Tumor Cell Isolation
Lei Xu et al.
PLOS ONE (2015)
Mechanisms of aromatase inhibitor resistance
Cynthia X. Ma et al.
NATURE REVIEWS CANCER (2015)
Promoting E2F1-mediated apoptosis in oestrogen receptor-α-negative breast cancer cells
Maria F. Montenegro et al.
BMC CANCER (2014)
Molecular profiling of single circulating tumor cells with diagnostic intention
Bernhard Polzer et al.
EMBO MOLECULAR MEDICINE (2014)
Ex vivo culture of circulating breast tumor cells for individualized testing of drug susceptibility
Min Yu et al.
SCIENCE (2014)
MUC1: a multifaceted oncoprotein with a key role in cancer progression
Sritama Nath et al.
TRENDS IN MOLECULAR MEDICINE (2014)
Differential effect of adjuvant taxane-based and taxane-free chemotherapy regimens the CK-19 mRNA-positive circulating tumour cells in patients with early breast cancer
N. Xenidis et al.
BRITISH JOURNAL OF CANCER (2013)
RT-qPCR work-flow for single-cell data analysis
Anders Stahlberg et al.
METHODS (2013)
Diagnostic leukapheresis enables reliable detection of circulating tumor cells of nonmetastatic cancer patients
Johannes C. Fischer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Challenges in the Enumeration and Phenotyping of CTC
Frank A. W. Coumans et al.
CLINICAL CANCER RESEARCH (2012)
Single Cell Profiling of Circulating Tumor Cells: Transcriptional Heterogeneity and Diversity from Breast Cancer Cell Lines
Ashley A. Powell et al.
PLOS ONE (2012)
Therapeutically activating RB: reestablishing cell cycle control in endocrine therapy-resistant breast cancer
Chellappagounder Thangavel et al.
ENDOCRINE-RELATED CANCER (2011)
Detection and HER2 Expression of Circulating Tumor Cells: Prospective Monitoring in Breast Cancer Patients Treated in the Neoadjuvant GeparQuattro Trial
Sabine Riethdorf et al.
CLINICAL CANCER RESEARCH (2010)
MUC1 regulates nuclear localization and function of the epidermal growth factor receptor
Benjamin G. Bitler et al.
JOURNAL OF CELL SCIENCE (2010)
Detection of cytokeratin-19 mRNA-positive cells in the peripheral blood and bone marrow of patients with operable breast cancer
A. Daskalaki et al.
BRITISH JOURNAL OF CANCER (2009)
Biological determinants of endocrine resistance in breast cancer
Elizabeth A. Musgrove et al.
NATURE REVIEWS CANCER (2009)
A highly specific real-time RT-PCR method for the quantitative determination of CK-19 mRNA positive cells in peripheral blood of patients with operable breast cancer
Aliki Stathopoulou et al.
INTERNATIONAL JOURNAL OF CANCER (2006)
Stochastic mRNA synthesis in mammalian cells
Arjun Raj et al.
PLOS BIOLOGY (2006)
It is not time to stop progesterone receptor testing in breast cancer
R Colomer et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Reduced PTEN expression predicts relapse in patients with breast carcinoma treated by tamoxifen
N Shoman et al.
MODERN PATHOLOGY (2005)
HER-2 gene amplification can be acquired as breast cancer progresses
SD Meng et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2004)
Validation of real-time RT-PCR for analysis of human breast cancer cell lines resistant or sensitive to treatment with antiestrogens
P de Cremoux et al.
ENDOCRINE-RELATED CANCER (2003)
Estrogen receptor breast cancer phenotypes in the surveillance, epidemiology, and end results database
WF Anderson et al.
BREAST CANCER RESEARCH AND TREATMENT (2002)
Stochastic gene expression in a single cell
MB Elowitz et al.
SCIENCE (2002)
Share Paper
